"You decide and we provide."
Cart 0

Sanofi-Regeneron's Praluent cuts cholesterol in Odyssey trials

reutersCOMPANYNEWS companyNews

PARIS, June 11 (Reuters) - France's Sanofi and partner Regeneron Pharmaceuticals said on Sunday their anti-cholesterol drug Praluent recorded positive results in its first dedicated studies involving patients with diabetes and high cholesterol.

Older Post Newer Post

Leave a comment

Please note, comments must be approved before they are published